BR0102326A - Bicarbonate based two-part solution for peritoneal dialysis or replacement in continuous renal replacement therapy - Google Patents

Bicarbonate based two-part solution for peritoneal dialysis or replacement in continuous renal replacement therapy

Info

Publication number
BR0102326A
BR0102326A BR0102326A BR0102326A BR0102326A BR 0102326 A BR0102326 A BR 0102326A BR 0102326 A BR0102326 A BR 0102326A BR 0102326 A BR0102326 A BR 0102326A BR 0102326 A BR0102326 A BR 0102326A
Authority
BR
Brazil
Prior art keywords
bicarbonate
concentrate
peritoneal dialysis
replacement
continuous renal
Prior art date
Application number
BR0102326A
Other languages
Portuguese (pt)
Inventor
Annick Duponchelle
Dirk Faict
Patrick Balteau
Jean-Pierre Hartman
Leo Martins
Francesco Peluso
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Priority to BR0102326A priority Critical patent/BR0102326A/en
Publication of BR0102326A publication Critical patent/BR0102326A/en

Links

Abstract

"SOLUçãO EM DUAS PARTES COM BASE EM BICARBONATO PARA DIáLISE PERITONEAL OU SUBSTITUIçãO EM TERAPIA DE SUBSTITUIçãO RENAL CONTìNUA". A presente invenção refere-se a dispositivos e métodos para estabilizar soluções com base em bicarbonato para diálise peritoneal ou hemofiltragem. As soluções com base em bicarbonato da presente invenção são formuladas e armazenadas em pelo menos duas partes - um concentrado de bicarbonato alcalino e um concentrado acídico. O concentrado de bicarbonato alcalino é ajustado para ter um pH de cerca de 8,6 a 10,0. O concentrado acídico é ajustado para ter um pH acídico, estável, variando de cerca de 1,0 a 3,0. Na mistura, embora exista alguma variação no pH da solução de bicarbonato mista, os inventores descobriram que com a seleção apropriada dos parâmetros dos concentrados, o pH da solução mista é sempre dentro de uma faixa fisiologicamente aceitável."BICARBONATE BASED TWO-PART SOLUTION FOR PERITONEAL DIALYSIS OR REPLACEMENT IN CONTINUOUS RENAL REPLACEMENT THERAPY". The present invention relates to devices and methods for stabilizing bicarbonate based solutions for peritoneal dialysis or hemofiltration. The bicarbonate-based solutions of the present invention are formulated and stored in at least two parts - an alkaline bicarbonate concentrate and an acidic concentrate. The alkaline bicarbonate concentrate is adjusted to have a pH of about 8.6 to 10.0. The acidic concentrate is adjusted to have a stable acidic pH, ranging from about 1.0 to 3.0. In the mixture, although there is some variation in the pH of the mixed bicarbonate solution, the inventors found that with the appropriate selection of concentrate parameters, the pH of the mixed solution is always within a physiologically acceptable range.

BR0102326A 2001-06-08 2001-06-08 Bicarbonate based two-part solution for peritoneal dialysis or replacement in continuous renal replacement therapy BR0102326A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR0102326A BR0102326A (en) 2001-06-08 2001-06-08 Bicarbonate based two-part solution for peritoneal dialysis or replacement in continuous renal replacement therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR0102326A BR0102326A (en) 2001-06-08 2001-06-08 Bicarbonate based two-part solution for peritoneal dialysis or replacement in continuous renal replacement therapy

Publications (1)

Publication Number Publication Date
BR0102326A true BR0102326A (en) 2003-04-01

Family

ID=3947423

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0102326A BR0102326A (en) 2001-06-08 2001-06-08 Bicarbonate based two-part solution for peritoneal dialysis or replacement in continuous renal replacement therapy

Country Status (1)

Country Link
BR (1) BR0102326A (en)

Similar Documents

Publication Publication Date Title
AR025019A1 (en) SOLUTION IN TWO PARTS CONTAINING USEFUL BICARBONATE FOR PERITONEAL DIALYSIS OR REPLACEMENT IN CONTINUOUS RENAL REPLACEMENT THERAPY, MULTIMARK CONTAINERS FOR STORAGE, AND THE METHOD FOR STABILIZING SUCH SOLUTIONS
EA200200431A1 (en) PHARMACEUTICAL COMPOSITIONS PROVIDING IMPROVED MEDICAL CONCENTRATIONS
EA200300776A1 (en) FENETHANOLAMINE DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES
TR200302242T2 (en) Pyrolopyrimidines as protein kinase inhibitors
BR0116466A (en) Dynamically stabilized contact lenses
EA200300503A1 (en) NEW MEDICINAL COMPOSITIONS BASED ON SALTS OF TIOTROPY AND SALTS OF SALMETEROL
BR9804330A (en) Solution for transperitoneal dialysis.
MXPA04004601A (en) Sulphonamide derivatives, the preparation thereof and the application of same as medicaments.
SE8801729D0 (en) PURINE DERIVATIVES FOR USE IN THERAPY
ATE493981T1 (en) ONCE DAILY DOSAGE FORMS OF TROSPIUM
ATE260650T1 (en) ORAL DOSAGE FORMS FOR ADMINISTRATION OF A FIXED COMBINATION OF TRAMADOL AND DICLOFENAC
DK1001792T3 (en) Use of physiologically acceptable vanadium compounds, salts and complexes
DE69828894D1 (en) OPHATOLOGIC COMPOSITION
MXPA04001256A (en) Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof.
TR200000737T2 (en) Substituted chroma derivatives.
DK1338270T3 (en) Use of a dihydrochalcone-rich phenol fraction in a cosmetic treatment
BR0111158A (en) Compound and physiological salts thereof, method for treating a median condition by tnf-a in a patient
AP1919A (en) Preparation compositions containing acid-unstable physiologically active compounds and process for producing the same
DE69821498D1 (en) USE OF AMIFOSTIN
BR0211245A (en) Protein-containing food comprising a cross-linking enzyme and a hydrocolloid
BR0102326A (en) Bicarbonate based two-part solution for peritoneal dialysis or replacement in continuous renal replacement therapy
DK174389D0 (en) USE OF 3-SUBSTITUTED 2-OXINDOL-1-CARBOXAMIDE COMPOUNDS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS FOR INHIBITING INTERLEUKIN-1 BIOSYNTHESIS
DE60222383D1 (en) MEDICAMENT FOR THE ADMINISTRATION OF AMIFOSTIN AND RELATED ACTIVE SUBSTANCES
DE69901506T2 (en) USE OF SODIUM CHLORIDE TO REDUCE THE GASTROINTESTINAL TOXICITY OF CAMPTOTECINE DERIVATIVES.
DE60019947D1 (en) PREVENTION OF COLORECTAL CANCER

Legal Events

Date Code Title Description
B07A Technical examination (opinion): publication of technical examination (opinion)
B09B Decision: refusal
B12B Appeal: appeal against refusal